hat
"Direct-aji medikaman antiviral anpeche viris la soti nan miltipliye epi byen souvan yo geri HCV. Vosevi bay yon opsyon tretman pou kèk pasyan ki pa te avèk siksè trete ak medikaman HCV lòt nan tan lontan an, "te di Edward Cox, MD, direktè a Biwo pou Antibiotics pwodwi yo nan Sant FDA a pou Evalyasyon Dwòg ak Rechèch.
eng
“Direct-acting antiviral drugs prevent the virus from multiplying and often cure HCV. Vosevi provides a treatment option for some patients who were not successfully treated with other HCV drugs in the past,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research.